Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000. - Wikidata - awgldk - TriplyDB

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.

http://www.wikidata.org/entity/Q40373597

about

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.Definition of cure in childhood acute myeloid leukemia.High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplant Global characteristics of childhood acute promyelocytic leukemia.Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo.Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study.Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias CD16NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice

P2860

Q34080807-5B08DC43-88A3-4389-8448-140E4FCA1312 Q34809196-F3292991-3CA2-435D-B358-D46A91D8C9DB Q35112199-057E758D-1AE7-44EF-8F2B-43E89529F31A Q35127974-28CE3198-16DF-424D-8905-9487DF4C2AFA Q35189037-FB1CD38A-2DCB-4045-A2B8-FB7BC61F73D0 Q35231673-13E49293-C48D-4F58-801D-60AA123D3E3A Q36100435-94427379-7934-448C-8D7C-8114D80917C2 Q37121665-9E37C3F8-7B0C-4815-8413-4AFDC912B6A2 Q37201944-0F90310F-C9A6-4EEC-B59B-A05144B59EE4 Q37276772-9BEF41D3-F2B6-4649-90C2-A356FD40A476 Q37874929-0CF02A5A-2E5F-403A-B3A8-8F2AD4380E5C Q39115390-DD4BB24A-FF6F-484E-89C8-559D18A10D4A Q39477447-E727DB8E-759E-490E-8B9A-288D20D8B662 Q39788816-DC6A55B9-03D3-4DD5-9B3D-C9B85B6C6721 Q57734345-42AA3197-ABA0-45D7-A5A6-384E267CABF3 Q58793790-28402A9B-C83B-4968-8472-B134B69F60E2

P2860

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.

http://www.wikidata.org/entity/Q40373597

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Successive clinical trials for ...... h Hospital, from 1980 to 2000.

@en

type

label

Successive clinical trials for ...... h Hospital, from 1980 to 2000.

@en

prefLabel

Successive clinical trials for ...... h Hospital, from 1980 to 2000.

@en

P1433

Q40373597-1CBA2B97-E682-4D25-A4FE-7B63F3147D23

P1476

Q40373597-8389B6BB-64D4-4838-87EB-49E8AB927697

P2093

Q40373597-0E396C1E-C43E-45AE-9F99-CF4A612F48B6

Q40373597-88AEE1D0-7F71-4492-AEA6-70ED00E97DC5

Q40373597-9B398B40-75C0-43DE-A8E1-F49EB6A3A8F0

Q40373597-AB6AD367-E46D-4237-8765-FAF33414C89C

Q40373597-F284D22F-5E8F-4342-B684-C41DF342AC9C

Q40373597-F475A855-4DC6-434A-9199-19BD74F9D33F

P2860

Q40373597-02AE5F48-B7F4-49E3-A8FC-F2C75045008F

Q40373597-0BE67AB8-77BD-4F69-BE96-F11A9898C0C9

Q40373597-26BAE223-4543-47E4-8A43-0DABA2145739

Q40373597-4016D193-2FD8-4E24-9363-680962E90DF5

Q40373597-495AA941-109F-41AA-89F7-105E4AB42E7E

Q40373597-7D648119-2221-456C-BEEA-39FE63CA9938

Q40373597-A24ADB9C-A6C1-4A8E-9420-0571E50AA813

Q40373597-B6AF6B44-0A6F-480B-9BCB-7ABEC405EEA5

Q40373597-C45FBF90-991A-4416-A100-26BE6F163F7D

Q40373597-E97D42F3-C918-405D-9F59-926EF9D403D3

P2888

Q40373597-EF7A57D6-ECA3-4227-8C58-9D4CF97D745F

P304

Q40373597-6CD4ABA7-DC56-4AA8-98F4-ABCD1C106475

P31

Q40373597-6D4A3698-1F7E-4026-93C2-F92824CF763B

P356

Q40373597-EC743117-76F2-4A46-B5D0-59E156700768

P433

Q40373597-FE4A6C45-8B34-4FA4-AA5D-8BE1EAE7B4F8

P478

Q40373597-C7AD6E70-8F75-4015-9401-182B38AA34A6

P577

Q40373597-F9792351-0E58-4623-91FA-9131DAEF28CC

P5875

Q40373597-51602667-827C-49AF-8EF0-D3BCB77FF879

P6179

Q40373597-69198B5C-DB26-43B3-8D31-8B98E67DFA59

P698

Q40373597-8277AA22-6F88-44F8-BA9B-9240ABB759E2

P921

Q40373597-326067D7-0DBC-4075-8F2C-BF47410561F7

P356

P1433

P1476

Successive clinical trials for ...... h Hospital, from 1980 to 2000.

@en

P2093

Hijiya N

http://www.w3.org/2001/XMLSchema#string

Pounds S

http://www.w3.org/2001/XMLSchema#string

Pui CH

http://www.w3.org/2001/XMLSchema#string

Razzouk BI

http://www.w3.org/2001/XMLSchema#string

Ribeiro RC

http://www.w3.org/2001/XMLSchema#string

Rubnitz JE

http://www.w3.org/2001/XMLSchema#string

P2860

Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia.

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a statistician's view.

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience.

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects.

P2888

P304

2125-2129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.LEU.2403872

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7487314

http://www.w3.org/2001/XMLSchema#string

P6179

1010915068

http://www.w3.org/2001/XMLSchema#string

P698

16281077

http://www.w3.org/2001/XMLSchema#string

P921